Study shows PromarkerD is significantly better than current standard of care tests eGFR and ACR for predicting future decline in kidney function in patients.
Alto Capital s Tony Locantro discusses news this week from Eagle Mountain Mining which has raised $16 million in a well-supported placement as well as.
BRISBANE, Australia, Aug. 12, 2021 /PRNewswire/ Treatment with diabetes drug canagliflozin lowers the PromarkerD risk score for developing diabetic kidney disease in patients with type 2